Early change in 18-fluorodeoxyglucose (FDG) uptake on positron emission tomography (PET) to predict response to preoperative systemic therapy (PST) in HER2-negative primary operable breast cancer: Translational breast cancer research consortium (TBCRC008).
Roisin M. Connolly
No relevant relationships to disclose
Jeffrey P Leal
No relevant relationships to disclose
Matthew P. Goetz
No relevant relationships to disclose
Zhe Zhang
No relevant relationships to disclose
Xian C Zhou
No relevant relationships to disclose
Joyce Mhlanga
No relevant relationships to disclose
Stacie Jeter
No relevant relationships to disclose
Bridget Walsh
No relevant relationships to disclose
Penny Powers
No relevant relationships to disclose
Jane Zorzi
No relevant relationships to disclose
John T. Carpenter
No relevant relationships to disclose
Anna Maria Storniolo
No relevant relationships to disclose
Stanley P. Watkins
No relevant relationships to disclose
John H. Fetting
No relevant relationships to disclose
Robert Stephen Miller
No relevant relationships to disclose
Kostandinos Sideras
No relevant relationships to disclose
Nagi Khouri
No relevant relationships to disclose
Edward Gabrielson
No relevant relationships to disclose
Richard L. Wahl
Honoraria - GE Healthcare
Research Funding - NIH/NCI
Vered Stearns
Research Funding - Celgene; Merck; Novartis; Pfizer